Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Thursday, July 26, 2012

World Hepatitis Day Live Twitter Chat: Hep B

Twitter Chat Announcement
Please join the CDC, Division of Viral Hepatitis (DVH) and the Hepatitis B Foundation for a World Hepatitis Day live twitter chat. We will be discussing Hepatitis B topics and available resources to educate and raise hepatitis B awareness around the world. Amanda Lewis of the CDC will be interviewing Dr. Thomas London.

What you need to get involved:
Join us with an interest in raising global hepatitis B awareness. Please use the #WHDchat hashtag to join the conversation and see what is being said.
Read Hep B Talk's blog for a guide to get you started with twitter. http://wp.hepb.org/?p=2008


Details
Date: Friday, July 27th
Time: 2:00 PM EDT
Duration: 1 hour
Hosts: CDC, Division of Viral Hepatitis & Hepatitis B Foundation
Hashtag to follow: #WHDchat











W. Thomas London, MD is internationally renowned for his many decades of work on hepatitis B and liver cancer, which started with his joining the research team that discovered the hepatitis B virus. Dr. London has been at the forefront of liver cancer prevention and has written extensively about hepatitis B from the perspective of an epidemiologist, a clinician and a virologist. As founder and director of the Liver Cancer Disease Prevention Division at Fox Chase Cancer Center in Philadelphia, PA, he developed one of the first successful community-based strategies to help people reduce their cancer risk through the early detection of chronic HBV infection. Dr. London has received the Distinguished Interdisciplinary Research Award from the American Cancer Society and the Distinguished Scientist Award from the Hepatitis B Foundation where he currently serves as Vice-Chair of the Board and as the Senior Medical Advisor.

Amanda Lewis is a Health Scientist in the CDC's Division of Viral Hepatitis (DVH), where she currently works on the Know More Hepatitis Campaign and leads the Division's social media efforts. She received her MPH in 2010 from Emory University's Rollins School of Public Health. She began working in viral hepatitis while a graduate student and was then hired to join DVH's Education and Training Team upon graduation.

No comments:

Post a Comment